Journal of the American Geriatrics Society · 2026
Opioid Use Is Associated With Lower Health-Related Quality of Life Among Community-Dwelling Older Australians: A Cross-Sectional Study From STAREE.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Turlejski Caroline, Gibson Brayden Ng, Wei Koh Harvey Jia, Chidwick Kendal, Gasevic Danijela, Moran Chris, Hopper Ingrid, Nelson Mark R, Reid Christopher M, Curtis Andrea J, Spark Simone, Flanagan Zachary, Wolfe Rory, Zoungas Sophia, Talic Stella
Аннотация
BACKGROUND: Prescribed opioid use among older adults may have a reciprocal negative association with health-related quality of life (HrQoL), yet evidence on this relationship remains limited. This study evaluated the association between prescription opioid use and HrQoL in community-dwelling older adults.
METHODS: We conducted a secondary cross-sectional analysis of baseline STAtins in Reducing Events in Elderly (STAREE) trial data, assessing the association between self-reported prescribed opioid use and HrQoL, via the 36-item Short Form Survey. Multivariable linear regression models assessed the association, with progressive adjustment for sociodemographic (Models 1 and 2), clinical (Model 3), and psychosocial factors (Model 4). Propensity score matching (PSM) was conducted to assess the robustness of the association.
FINDINGS: The cohort included 479 opioid users and 9492 non-opioid users. users. In unadjusted analyses, opioid users had substantially lower mean HrQoL scores than non-users (β = -14.30; 95% CI: -15.59, -13.02). Adjustment for confounders attenuated the association, but it remained statistically significant in the fully adjusted model (β = -7.58; 95% CI: -8.80, -6.35). Lower scores among opioid users were observed across all HrQoL domains (Physical Functioning, Social Functioning, Role Limitations, Vitality, Bodily Pain, General Health and Mental Health), with the largest differences in physical functioning (approximately 20-25 points lower).
CONCLUSION: Opioid use is associated with significantly poorer HrQoL in community-dwelling older adults, highlighting the importance of routinely assessing quality of life, functional status, and psychosocial factors among persons who use opioids.
TRIAL REGISTRATION: This study was approved by Monash Human Research Ethics Committee (ID: 21528).
METHODS: We conducted a secondary cross-sectional analysis of baseline STAtins in Reducing Events in Elderly (STAREE) trial data, assessing the association between self-reported prescribed opioid use and HrQoL, via the 36-item Short Form Survey. Multivariable linear regression models assessed the association, with progressive adjustment for sociodemographic (Models 1 and 2), clinical (Model 3), and psychosocial factors (Model 4). Propensity score matching (PSM) was conducted to assess the robustness of the association.
FINDINGS: The cohort included 479 opioid users and 9492 non-opioid users. users. In unadjusted analyses, opioid users had substantially lower mean HrQoL scores than non-users (β = -14.30; 95% CI: -15.59, -13.02). Adjustment for confounders attenuated the association, but it remained statistically significant in the fully adjusted model (β = -7.58; 95% CI: -8.80, -6.35). Lower scores among opioid users were observed across all HrQoL domains (Physical Functioning, Social Functioning, Role Limitations, Vitality, Bodily Pain, General Health and Mental Health), with the largest differences in physical functioning (approximately 20-25 points lower).
CONCLUSION: Opioid use is associated with significantly poorer HrQoL in community-dwelling older adults, highlighting the importance of routinely assessing quality of life, functional status, and psychosocial factors among persons who use opioids.
TRIAL REGISTRATION: This study was approved by Monash Human Research Ethics Committee (ID: 21528).